Lymphedema Diagnostics Market 2027 by Technology, Indication, End User , and Geography | The Insight Partners

Lymphedema Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Technology (Magnetic Resonance Imaging, Ultrasound Imaging, Lymphoscintigraphy, Computed Tomography, X-Ray Lymphography, Bioimpedance Analysis, Near-Infrared Fluorescence Imaging); Indication (Cancer, Inflammatory Diseases, Cardiovascular Disease, Others); End User (Hospitals, Diagnostic Centers, Research and Academic Institutes), and Geography

Report Code: TIPRE00008972 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Lymphedema is a health condition during which arms or legs swell due to damage or poor function of the lymphatic systems. It affects only one of the extremities; however, in some cases, it affects both extremities. The lymphedema may be classified as primary and secondary and is diagnosed by imaging diagnostics and other imaging techniques.

MARKET DYNAMICS

The lymphedema diagnostics market is expected to grow due to the rising prevalence of lymphedema, increasing incidences of cancer and cardiovascular diseases, and others. The market is expected to have growth opportunities due to the rising healthcare industry in the developing regions.

MARKET SCOPE

The "Global Lymphedema Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of lymphedema diagnostics market with detailed market segmentation by technology, indication, end user, and geography. The global lymphedema diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading lymphedema diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global lymphedema diagnostics market is segmented on the basis of technology, indication, and end user. Based on the technology the market is classified as magnetic resonance imaging, ultrasound imaging, lymphoscintigraphy, computed tomography, x-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging. On the basis of indication the market is divided into cancer, inflammatory diseases, cardiovascular disease, and others. And based on the end user the market is classified as hospitals, diagnostic centers, and research & academic institutes.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global lymphedema diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lymphedema diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting lymphedema diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lymphedema diagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS

The reports cover key developments in the lymphedema diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from lymphedema diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for lymphedema diagnostics market in the global market. Below mentioned is the list of few companies engaged in the lymphedema diagnostics market.

The report also includes the profiles of key lymphedema diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- General Electric Company
- Siemens AG
- Koninklijke Philips N.V.
- Canon, Inc.
- Stryker Corporation
- Hitachi, Ltd.
- Neusoft Corporation
- Esaote SPA
- Shimadzu Corporation
- Mindray Medical International Limited

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lymphedema Diagnostics Market - By Technology
1.3.2 Lymphedema Diagnostics Market - By Indication
1.3.3 Lymphedema Diagnostics Market - By End User
1.3.4 Lymphedema Diagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LYMPHEDEMA DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LYMPHEDEMA DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LYMPHEDEMA DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. LYMPHEDEMA DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. LYMPHEDEMA DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LYMPHEDEMA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. MAGNETIC RESONANCE IMAGING
7.3.1. Overview
7.3.2. Magnetic Resonance Imaging Market Forecast and Analysis
7.4. ULTRASOUND IMAGING
7.4.1. Overview
7.4.2. Ultrasound Imaging Market Forecast and Analysis
7.5. LYMPHOSCINTIGRAPHY
7.5.1. Overview
7.5.2. Lymphoscintigraphy Market Forecast and Analysis
7.6. COMPUTED TOMOGRAPHY
7.6.1. Overview
7.6.2. Computed Tomography Market Forecast and Analysis
7.7. X-RAY LYMPHOGRAPHY
7.7.1. Overview
7.7.2. X-Ray Lymphography Market Forecast and Analysis
7.8. BIOIMPEDANCE ANALYSIS
7.8.1. Overview
7.8.2. Bioimpedance Analysis Market Forecast and Analysis
7.9. NEAR-INFRARED FLUORESCENCE IMAGING
7.9.1. Overview
7.9.2. Near-Infrared Fluorescence Imaging Market Forecast and Analysis
7.9.3. ICG Lymphography Market
7.9.3.1. Overview
7.9.3.2. ICG Lymphography Market Forecast and Analysis
7.9.4. Fluorescein Sodium Microlymphangiography Market
7.9.4.1. Overview
7.9.4.2. Fluorescein Sodium Microlymphangiography Market Forecast and Analysis
8. LYMPHEDEMA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.4. INFLAMMATORY DISEASES
8.4.1. Overview
8.4.2. Inflammatory Diseases Market Forecast and Analysis
8.5. CARDIOVASCULAR DISEASE
8.5.1. Overview
8.5.2. Cardiovascular Disease Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. LYMPHEDEMA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. RESEARCH AND ACADEMIC INSTITUTES
9.5.1. Overview
9.5.2. Research and Academic Institutes Market Forecast and Analysis
10. LYMPHEDEMA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Lymphedema Diagnostics Market Overview
10.1.2 North America Lymphedema Diagnostics Market Forecasts and Analysis
10.1.3 North America Lymphedema Diagnostics Market Forecasts and Analysis - By Technology
10.1.4 North America Lymphedema Diagnostics Market Forecasts and Analysis - By Indication
10.1.5 North America Lymphedema Diagnostics Market Forecasts and Analysis - By End User
10.1.6 North America Lymphedema Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Lymphedema Diagnostics Market
10.1.6.1.1 United States Lymphedema Diagnostics Market by Technology
10.1.6.1.2 United States Lymphedema Diagnostics Market by Indication
10.1.6.1.3 United States Lymphedema Diagnostics Market by End User
10.1.6.2 Canada Lymphedema Diagnostics Market
10.1.6.2.1 Canada Lymphedema Diagnostics Market by Technology
10.1.6.2.2 Canada Lymphedema Diagnostics Market by Indication
10.1.6.2.3 Canada Lymphedema Diagnostics Market by End User
10.1.6.3 Mexico Lymphedema Diagnostics Market
10.1.6.3.1 Mexico Lymphedema Diagnostics Market by Technology
10.1.6.3.2 Mexico Lymphedema Diagnostics Market by Indication
10.1.6.3.3 Mexico Lymphedema Diagnostics Market by End User
10.2. EUROPE
10.2.1 Europe Lymphedema Diagnostics Market Overview
10.2.2 Europe Lymphedema Diagnostics Market Forecasts and Analysis
10.2.3 Europe Lymphedema Diagnostics Market Forecasts and Analysis - By Technology
10.2.4 Europe Lymphedema Diagnostics Market Forecasts and Analysis - By Indication
10.2.5 Europe Lymphedema Diagnostics Market Forecasts and Analysis - By End User
10.2.6 Europe Lymphedema Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Lymphedema Diagnostics Market
10.2.6.1.1 Germany Lymphedema Diagnostics Market by Technology
10.2.6.1.2 Germany Lymphedema Diagnostics Market by Indication
10.2.6.1.3 Germany Lymphedema Diagnostics Market by End User
10.2.6.2 France Lymphedema Diagnostics Market
10.2.6.2.1 France Lymphedema Diagnostics Market by Technology
10.2.6.2.2 France Lymphedema Diagnostics Market by Indication
10.2.6.2.3 France Lymphedema Diagnostics Market by End User
10.2.6.3 Italy Lymphedema Diagnostics Market
10.2.6.3.1 Italy Lymphedema Diagnostics Market by Technology
10.2.6.3.2 Italy Lymphedema Diagnostics Market by Indication
10.2.6.3.3 Italy Lymphedema Diagnostics Market by End User
10.2.6.4 Spain Lymphedema Diagnostics Market
10.2.6.4.1 Spain Lymphedema Diagnostics Market by Technology
10.2.6.4.2 Spain Lymphedema Diagnostics Market by Indication
10.2.6.4.3 Spain Lymphedema Diagnostics Market by End User
10.2.6.5 United Kingdom Lymphedema Diagnostics Market
10.2.6.5.1 United Kingdom Lymphedema Diagnostics Market by Technology
10.2.6.5.2 United Kingdom Lymphedema Diagnostics Market by Indication
10.2.6.5.3 United Kingdom Lymphedema Diagnostics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Lymphedema Diagnostics Market Overview
10.3.2 Asia-Pacific Lymphedema Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Lymphedema Diagnostics Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Lymphedema Diagnostics Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Lymphedema Diagnostics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Lymphedema Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Lymphedema Diagnostics Market
10.3.6.1.1 Australia Lymphedema Diagnostics Market by Technology
10.3.6.1.2 Australia Lymphedema Diagnostics Market by Indication
10.3.6.1.3 Australia Lymphedema Diagnostics Market by End User
10.3.6.2 China Lymphedema Diagnostics Market
10.3.6.2.1 China Lymphedema Diagnostics Market by Technology
10.3.6.2.2 China Lymphedema Diagnostics Market by Indication
10.3.6.2.3 China Lymphedema Diagnostics Market by End User
10.3.6.3 India Lymphedema Diagnostics Market
10.3.6.3.1 India Lymphedema Diagnostics Market by Technology
10.3.6.3.2 India Lymphedema Diagnostics Market by Indication
10.3.6.3.3 India Lymphedema Diagnostics Market by End User
10.3.6.4 Japan Lymphedema Diagnostics Market
10.3.6.4.1 Japan Lymphedema Diagnostics Market by Technology
10.3.6.4.2 Japan Lymphedema Diagnostics Market by Indication
10.3.6.4.3 Japan Lymphedema Diagnostics Market by End User
10.3.6.5 South Korea Lymphedema Diagnostics Market
10.3.6.5.1 South Korea Lymphedema Diagnostics Market by Technology
10.3.6.5.2 South Korea Lymphedema Diagnostics Market by Indication
10.3.6.5.3 South Korea Lymphedema Diagnostics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Lymphedema Diagnostics Market Overview
10.4.2 Middle East and Africa Lymphedema Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Lymphedema Diagnostics Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Lymphedema Diagnostics Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Lymphedema Diagnostics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Lymphedema Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Lymphedema Diagnostics Market
10.4.6.1.1 South Africa Lymphedema Diagnostics Market by Technology
10.4.6.1.2 South Africa Lymphedema Diagnostics Market by Indication
10.4.6.1.3 South Africa Lymphedema Diagnostics Market by End User
10.4.6.2 Saudi Arabia Lymphedema Diagnostics Market
10.4.6.2.1 Saudi Arabia Lymphedema Diagnostics Market by Technology
10.4.6.2.2 Saudi Arabia Lymphedema Diagnostics Market by Indication
10.4.6.2.3 Saudi Arabia Lymphedema Diagnostics Market by End User
10.4.6.3 U.A.E Lymphedema Diagnostics Market
10.4.6.3.1 U.A.E Lymphedema Diagnostics Market by Technology
10.4.6.3.2 U.A.E Lymphedema Diagnostics Market by Indication
10.4.6.3.3 U.A.E Lymphedema Diagnostics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Lymphedema Diagnostics Market Overview
10.5.2 South and Central America Lymphedema Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America Lymphedema Diagnostics Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Lymphedema Diagnostics Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Lymphedema Diagnostics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Lymphedema Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Lymphedema Diagnostics Market
10.5.6.1.1 Brazil Lymphedema Diagnostics Market by Technology
10.5.6.1.2 Brazil Lymphedema Diagnostics Market by Indication
10.5.6.1.3 Brazil Lymphedema Diagnostics Market by End User
10.5.6.2 Argentina Lymphedema Diagnostics Market
10.5.6.2.1 Argentina Lymphedema Diagnostics Market by Technology
10.5.6.2.2 Argentina Lymphedema Diagnostics Market by Indication
10.5.6.2.3 Argentina Lymphedema Diagnostics Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LYMPHEDEMA DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. GENERAL ELECTRIC COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SIEMENS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. KONINKLIJKE PHILIPS N.V.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CANON, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. STRYKER CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HITACHI, LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NEUSOFT CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ESAOTE SPA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SHIMADZU CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MINDRAY MEDICAL INTERNATIONAL LIMITED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. General Electric Company
2. Siemens AG
3. Koninklijke Philips N.V.
4. Canon, Inc.
5. Stryker Corporation
6. Hitachi, Ltd.
7. Neusoft Corporation
8. Esaote SPA
9. Shimadzu Corporation
10. Mindray Medical International Limited
TIPRE00008972
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking